2162 fundamentals
KEYMED BIOSCIENCES INC revenue breakdown overview
KEYMED BIOSCIENCES INC revenue for the last year amounted to 455.67 M HKD, the most of which — 464.18 M HKD — came from its highest performing source at the moment, Biopharmaceutical Research & Development and Commercialisation, the year earlier bringing 391.27 M HKD. The greatest contribution to the revenue figure was made by Overseas — last year it brought KEYMED BIOSCIENCES INC 424.09 M HKD, and the year before that — 390.28 M HKD.
By source
By country